COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification
18/06/2018
(Oslo, Norway, June 15, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 25.000 shares in Solon Eiendom ASA at a price of NOK 29.8763. Following this [...]
Nexstim raises EUR 0.96 million via a directed issue of new shares to Capricorn Health-tech Fund - Funds to be used to support the commercialisation of its NBT® system
18/06/2018
Company announcement, Helsinki, 18 June 2018 at 9:00 am Nexstim raises EUR 0.96 million via a directed issue of new shares to Capricorn Health-tech Fund - Funds to be used to support the commercialisation of its NBT® [...]
Shire plc : Rule 2.9 Announcement
18/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 June 2018 Shire [...]
Novartis International AG: Alcon AcrySof® IQ PanOptix® trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
18/06/2018
Better visual outcomes for patients with the AcrySof IQ PanOptix intraocular lens at near and intermediate distance vision[1] Detailed findings presented at World Ophthalmology Congress 2018 Recent survey reveals 82% of [...]
Innate Pharma to participate in the Citi 2018 European Healthcare Conference on June 20, 2018
18/06/2018
Marseille, France, June 18, 2018, 07:00 AM CEST Innate Pharma (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the Citi 2018 European Healthcare Conference on June 20, 2018 [...]
INNATE PHARMA PARTICIPERA A LA 2018 EUROPEAN HEALTHCARE CONFERENCE DE CITI LE 20 JUIN 2018
18/06/2018
Marseille le 18 juin 2018, 7h00 CEST Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce aujourd'hui qu'elle sera présente à la Conférence santé européenne 2018 de Citi le 20 juin 2018 à [...]
Idorsia is initiating REACT - Phase 3 registration study with clazosentan
18/06/2018
REACT assesses clazosentan for the prevention of clinical deterioration due to vasospasm-related delayed cerebral ischemia following subarachnoid hemorrhage Japanese registration program with clazosentan is on-track to [...]
Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing
18/06/2018
MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy Presented at the 2018 Annual Cure SMA Conference
16/06/2018
First Study of Muscle-Directed Therapy in Patients with SMA Showed Potentially Clinically Meaningful Effects on Six Minute Walk Distance and Maximal Expiratory Pressure SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE [...]
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
16/06/2018
Overall response rate was 52% and median duration of response was not reached at a median follow-up of 14 months, signifying responses were durable[1] Patients had a 65% chance of being relapse-free one year after onset [...]
Alberta Business Community Raises $640,000 for 2018 CEO Rescue in the Rockies for STARS Fundraiser
16/06/2018
CEOs “rescued” from mountaintop after achieving fundraising goals and completing survival challenges CALGARY, Alberta, June 15, 2018 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service (STARS) is pleased to announce [...]
Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders
16/06/2018
NEW HAVEN, Conn., June 15, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2018 Annual Meeting of Shareholders, originally scheduled for 9:30 a.m [...]
Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15/06/2018
BOTHELL, Wash., June 15, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
15/06/2018
RADNOR, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018
15/06/2018
Geneva, Switzerland and Boston, MA - June 15, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Kalytera Announces Second Payments Agreement with The Salzman Group of Israel
15/06/2018
SAN FRANCISCO and TEL AVIV, Israel, June 15, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that it has entered into an agreement [...]
Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in Greater
15/06/2018
YARDLEY, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter Miller [...]
Immunomedics Announces Closing of Public Offering of Common Stock
15/06/2018
MORRIS PLAINS, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Grant of Warrants
15/06/2018
June 15, 2018 Announcement no. 11 In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the Articles of Association, the Board of Directors of BioPorto A/S [...]

Pages